Leads clinical bioanalytical assay strategy and lifecycle management for PK, PD, immunogenicity, and biomarker assays. Oversees assay development, validation, sample analysis, data quality, CRO laboratories, regulatory submissions, inspections, clinical study support, budgets, and compliance. Provides scientific leadership across small-molecule and biologic programs while troubleshooting methods and maintaining current knowledge of bioanalytical technologies and global regulatory expectations.
- JOB INFORMATIONJOB SUMMARYAs a member of the Clinical Assay Group within Development China Clinical Pharmacology, Clinical Assay Lead will play a critical role in supporting clinical strategies in all stages of drug development and post marketing activities through scientific and technical leadership, oversight and management of external and internal partners involved in delivering quality, timely, and regulatory compliant PK, PD, immunogenicity and biomarker analytical assays and data (as relevant to Small Molecule, Biologics or biomarker).JOB RESPONSIBILITIES
- Serves as a member of the clinical study team and analytical subject matter expert for executing clinical study setup & conduct, contributing to the study protocol development & review, preparing submissions, addressing regulatory queries, implementing bioanalytical strategies & assays, and delivering regulatory compliant data and reports within program timelines.
- Leads and oversees small or large molecule PK, PD, and immunogenicity (ADA and Nab) assay and biomarker assay lifecycle management from early stage to registration. Analytical strategy execution, method design, development, and validation, as well as data quality review will be involved. Corresponds sample analyses & reports to meet evolving program objectives and regulatory expectations. Assists CROs with effective troubleshooting of the bioanalytical assay and issue resolution.
- Functions as key point of contact with external & internal laboratories and supports (or leads, as appropriate) selection, qualification, performance evaluation, and periodic audits of CRO laboratories conducting clinical PK, PD and immunogenicity assays (as relevant to the role).
- Supports the clinical trial conduct within scope of the Clinical Assay Group responsibilities, including development and review of documents and processes such as CRF and data setup, clinical site lab manual, sample management & reconciliation, bioanalytical study planning & reporting, budgeting & invoicing, compliance with clinical SOPs & policies, and regulatory inspection readiness & conduct.
- Contributes to the development of Best Practices, processes, templates, and policies.
- Maintains up-to-date knowledge of current and novel chromatographic separation/mass spectrometry based detection, ligand binding technologies & techniques or bioanalytical techniques commonly used for Biomarkers (as relevant to the role), global regulatory guidances & expectations, and industry best practices.
RESOURCES MANAGED
Indirect responsibility for the clinical budget allocated to bioanalytical support of the clinical study or program. Develop bioanalysis agreements with commercial and academic laboratories. Responsible for approval of invoices for work overseen. Member of HGRAC task force, Clinical sub-teams and study teams.
ORGANIZATIONAL RELATIONSHIPS
Reports to Clinical Assay Group Lead Frequent interaction with colleagues in Clinical Pharmacology, Clinicians, Contract Research Organizations (CROs), Clinical Operations, Statistics, Regulatory, Finance, and external collaborators, as appropriate.
As Specific to Biomarker:
Hands-on experience with the development, validation and troubleshooting of the methods commonly used for Biomarkers, including but limited to flow cytometry, FISH, IHC and NGS
As Specific to Biologics:
Hands-on experience with the development, validation and troubleshooting of the methods for PK and immunogenicity (including the determination of assay cut points, tolerance, and sensitivity along with experience implementing ACE, BEAD, and SPEAD methodologies) and clinical sample analysis. Understanding of critical reagent generation & lifecycle management Experience with biosimilars, gene therapy, multi-domain therapeutics, immunocapture, protein binding, cell based assays and technologies such as RT-PCR, qPCR, ELISPOT, AMS and FACs.
As Specific to Small Molecule:
Hands-on experience with the development, validation and troubleshooting of the methods for LC/MS quantitation, along with experience implementing HPLC/UPLC/GC separation, sample preparation techniques, mass spectrometry detection platforms and their application in clinical sample analysis. Experience with human ADME, protein binding, immunocapturing hybrid assays and technologies such as LC-AMS and HRMS.
PREFERRED QUALIFICATIONS (BASED ON THE POSITION LEVEL AND REQUIRED EXPERIENCE)
Demonstrated CRO management and outsourcing experience. Experience with regulatory inspections. Experience preparing regulatory submissions and addressing regulatory queries. Understanding of clinical trial design and overall principles of clinical development and related disciplines (e.g., pharmacokinetics and clinical pharmacology, statistics, ADME, formulation and drug product). Prior experience with training, mentoring or managing colleagues.
QUALIFICATIONS / SKILLS
EDUCATION
PhD or equivalent in biology or analytical chemistry/chemistry. M.S. degrees will be considered based on relevant industry experience
BASIC QUALIFICATIONS
Minimum of 5-8 years of industry or bioanalytical experience with PK and/or immunogenicity assay and biomarker assay development, validation, and sample analyses using chromatographic/mass spectrometry, ligand binding (ELISA and ECL) or other methodologies like flow cytometry, FISH and etc. (as relevant to the role). Working knowledge of GxP regulations governing conduct of clinical trials and regulatory guidances and expectations relevant to regulated bioanalysis. Subject matter expert in regulated bioanalysis small organic molecules or Biologics and understanding of bioanalytical techniques commonly used for Biomarkers. In depth knowledge of GxP regulations governing conduct of clinical trials and regulatory guidances and expectations relevant to regulated bioanalysis. Demonstrated ability to think strategically, work in a highly matrixed environment, and execute multiple projects simultaneously. Highly effective communication skills: verbal, written, and presentation.
#LI-PFE
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
To learn more about acceptable and prohibited uses of AI during the recruitment process, please review our candidate AI-use guidelines available on Pfizer Careers .
Medical
What you need to know about the Boston Tech Scene
Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories

